Citation:Schröer-Günther MA, Wolff RF, Westwood ME, Scheibler FJ, Schürmann C, Baumert BG, et al 2012

Citation

Schröer-Günther MA, Wolff RF, Westwood ME, Scheibler FJ, Schürmann C, Baumert BG, et al. F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review. Syst Rev 2012 Dec 13;1:62 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23237499.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Schröer-Günther MA, Wolff RF, Westwood ME, Scheibler FJ, Schürmann C, Baumert BG, et al 2012	What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?	Tamsin Parrish	completed
Schröer-Günther MA, Wolff RF, Westwood ME, Scheibler FJ, Schürmann C, Baumert BG, et al 2012 2	What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?	Lani Teddy	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?|]] (compare critical appraisals)
• [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?|]] (compare critical appraisals)

Cited by

1. What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?
2. What investigations should be performed when in-transit and/or regional node disease (stage III melanoma) is diagnosed?
3. What investigations should be performed when stage IV melanoma is diagnosed?